Al-Harmain Pharma (India) Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2004.
2004 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Al-Harmain Pharma (India) Private Limited

Al-Harmain Pharma (India) Private Limited, a active private limited company, was established on 02 September 2004 in New Delhi, Delhi, India. Engaging in ayurvedic products & services within the trade sector, it holds CIN: U24232DL2004PTC128769. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.62 Cr.

It upholds a compliant status. Its leadership includes Mohd Tariq (Director), Saboor Ahmed Siddiqui (Director). Past directors included Mohammed Mohsin Siddiqui, Shabana Akram. It holds ₹1.02 M open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 27 December 2025, with the balance sheet filed on 31 March 2025. It is based at L-27, Second Floor, Gali No-9. Zakir Nagar Okhla, New Delhi, Delhi, 110025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2004PTC128769

  • Registration Number

    128769

  • Incorporation Date

    02 September 2004

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.62 Cr

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.62 Cr
  • Company Age 21 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.02 M
  • Satisfied Charges ₹ 2.00 Cr
  • Revenue Growth **** -31.55%
  • Profit Growth **** -0.24%
  • Ebitda **** 407.86%
  • Net Worth 5.32%
  • Total Assets -25.80%
Company report

Al-Harmain Pharma (India) Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Al-Harmain Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Al-Harmain Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohd Tariq Director 02 Sep 2004 Current
Saboor Ahmed Siddiqui Director 02 Sep 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2021 Past
Pramod Abcsdd Director 21 Dec 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Al-Harmain Pharma (India).

Al-Harmain Pharma (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 31.55% decrease. The company also saw a slight decrease in profitability, with a 0.24% decrease in profit. The company's net worth moved up by a moderate rise of 5.32%.

Al-Harmain Pharma (India) revenue growth over time
Al-Harmain Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -31.55%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.42%
*******
*******
*******
*******
Total Assets
*******
 -25.80%
*******
*******
*******
*******
Profit or Loss
*******
 -0.24%
*******
*******
*******
*******
Net Worth
*******
 5.32%
*******
*******
*******
*******
EBITDA
*******
 407.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Al-Harmain Pharma (India)?

In 2020, Al-Harmain Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,022,498.00

Satisfied Charges

₹20,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
04 Aug 2022 Hdfc Bank Limited ₹0.41 M Open
01 Jul 2022 Hdfc Bank Limited ₹0.61 M Open
27 Nov 2019 Others ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Al-Harmain Pharma (India)?

Unlock and access historical data on people associated with Al-Harmain Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Al-Harmain Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Al-Harmain Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Al-Harmain Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Al-Harmain Pharma (India) Private Limited last Annual general meeting of members was held on 27 Dec 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Al-Harmain Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Charges

    Progress on A charge registered on 27 Nov 2019 via Charge ID 100315004 with Others was fully satisfied on 24 Nov 2023. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.04 Cr with Charge ID 100628159 was registered on 04 Aug 2022. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.06 Cr with Charge ID 100873490 was registered on 01 Jul 2022. was documented.

  • Charges

    A charge with Others of Rs. 2.00 Cr registered on 27 Nov 2019 with Charge ID 100315004 was modified on 29 Nov 2019. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Al-Harmain Pharma (India) Private Limited?

The CIN of Al-Harmain Pharma (India) Private Limited is U24232DL2004PTC128769.

Where is Al-Harmain Pharma (India) Private Limited headquartered?

Al-Harmain Pharma (India) Private Limited is headquartered at L-27, Second Floor, Gali No-9. Zakir Nagar Okhla, New Delhi, Delhi, 110025.

When was Al-Harmain Pharma (India) Private Limited incorporated?

Al-Harmain Pharma (India) Private Limited was incorporated on 02 September 2004.

Who are the current directors of Al-Harmain Pharma (India) Private Limited?

The current directors of Al-Harmain Pharma (India) Private Limited are

What is the primary industry of Al-Harmain Pharma (India) Private Limited?

The primary industry of Al-Harmain Pharma (India) Private Limited is Trade.

Is Al-Harmain Pharma (India) Private Limited a listed company?

Al-Harmain Pharma (India) Private Limited is unlisted.

What is the capital structure of Al-Harmain Pharma (India) Private Limited?

The authorized capital of Al-Harmain Pharma (India) Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.62 Cr.

What is the compliance status of Al-Harmain Pharma (India) Private Limited?

The compliance status of Al-Harmain Pharma (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available